Stock ONCT ONCTERNAL THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Oncternal Therapeutics, Inc.

Equities

ONCT

US68236P2065

Delayed Nasdaq
Other stock markets
 09:31:26 2024-04-26 am EDT 		5-day change 1st Jan Change
8 USD -3.03% Intraday chart for Oncternal Therapeutics, Inc. -9.71% -25.40%
Apr. 18 Oncternal Announces First Patient Dosed in Fourth Cohort of Phase 1/2 Study of ONCT-534 for the Treatment of R/R Metastatic Castration-Resistant Prostate Cancer CI
Apr. 15 HC Wainwright Cuts Oncternal Therapeutics' Price Target to $28 From $30, Keeps Buy Rating MT

Chart calendar Oncternal Therapeutics, Inc.

a22d1c773561026b3044f7a55679c5b0.Xz7beAPEFC4lp-RyAa_3QfxU0UqNrcgLvmEeIqPD0js.LGntLDa-c1QX3rYRONbALr0FoDnp96Zo-CtyS8-S4Q4-Bo4cZJUkHxDMsQ~8a52de211de427dba789c726d07f687c

Upcoming events on Oncternal Therapeutics, Inc.

2024-05-01 Q1 2024 Earnings Release (Projected)
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-05 Q4 2024 Earnings Release (Projected)

Past events on Oncternal Therapeutics, Inc.

2024-03-19 11:00 am Investor Meeting - Key Opinion Leader
2024-03-07 05:00 pm Q4 2023 Earnings Call
2024-03-07 04:01 pm Q4 2023 Earnings Release
2024-02-13 04:40 pm Oppenheimer Healthcare Life Sciences Conference
2024-01-07 Reverse Split: 1 of 20
2023-11-09 05:00 pm Q3 2023 Earnings Call
2023-11-09 04:01 pm Q3 2023 Earnings Release
2023-09-18 Northland Capital Markets Institutional Investor Conference
2023-09-11 H.C. Wainwright Global Investment Conference
2023-08-10 05:00 pm Q2 2023 Earnings Call
2023-08-10 04:01 pm Q2 2023 Earnings Release
2023-06-28 11:00 am Annual General Meeting
2023-06-07 04:30 pm Jefferies Global Healthcare Conference
2023-05-04 05:00 pm Q1 2023 Earnings Call
2023-05-04 04:01 pm Q1 2023 Earnings Release
2023-04-18 01:30 pm Investor Meeting - Oppenheimer & Co
2023-04-03 05:00 pm Business Update Call
2023-03-14 03:20 pm Oppenheimer Healthcare Conference
2023-03-09 05:00 pm Q4 2022 Earnings Call
2023-03-09 04:01 pm Q4 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		3,38
2,37
42.2%		4,32
4,82
-10.4%		1,49
1,60
-6.9%		0,79
0,63
24.9%
0,54

EBITDA
Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		-17,5
-20,0
12.15%		-31,4
-35,6
11.82%		-44,9
-45,3
0.82%		-41,7
-41,7
0.08%
-39,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-31,3
-35,4
11.39%		-44,2
-44,7
1.24%		-39,5
-39,3
-0.42%
-37,2

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-31,3
-35,4
11.39%		-44,2
-44,9
1.71%		-39,5
-39,5
0.08%
-37,8

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		-12,8
-14,4
11.11%		-16,8
-16,8
0.2%		-13,4
-13,4
-0.26%
-10,7

Announcement Date11/03/2110/03/2209/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,56
1,06
-47.39%		0,75
0,53
42.1%		0,19
0,46
-58.39%		0,38
0,25
49.9%		0,17
0,28
-39.82%		0,20
0,14
42.1%		0,11
0,17
-37.95%		0,18
0,13
43.2%		0,30
0,14
116%
0,13


0,13


0,13


0,14

EBIT
Million USD		Released
Forecast
Spread 		-8,08
-12,3
34.22%		-9,91
-9,99
0.76%		-11,8
-11,4
-3.11%		-11,3
-12,6
10.16%		-11,9
-12,3
3.07%		-12,1
-11,9
-2.23%		-9,55
-10,1
5.56%		-10,4
-9,09
-14.25%		-9,64
-9,67
0.33%
-9,53


-9,53


-9,81


-10,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-8,07
-12,1
33.28%		-9,90
-12,4
20.1%		-11,7
-11,5
-2.18%		-11,1
-12,2
8.58%		-11,4
-11,9
4.58%		-11,5
-11,1
-3.29%		-8,97
-8,98
0.1%		-9,86
-8,24
-19.64%		-9,16
-9,00
-1.84%
-9,06


-8,96


-9,19


-10,0

Net income
Million USD		Released
Forecast
Spread 		-8,07
-12,1
33.28%		-9,90
-11,9
17.08%		-11,7
-12,4
5.13%		-11,1
-13,1
15.08%		-11,4
-12,2
6.27%		-11,5
-11,7
1.97%		-8,97
-9,81
8.59%		-9,86
-8,74
-12.85%		-9,16
-9,20
0.38%
-9,08


-9,11


-9,41


-10,2

EPS
USD		Released
Forecast
Spread 		-3,40
-4,80
29.17%		-4,00
-4,80
16.67%		-4,60
-5,00
8%		-4,20
-4,90
14.29%		-4,00
-4,20
4.76%		-4,00
-3,97
-0.72%		-3,00
-3,33
10%		-3,40
-2,90
-17.24%		-3,11
-3,09
-0.81%
-2,88


-2,61


-2,62


-2,70

Announcement Date10/03/2205/05/2209/08/2203/11/2209/03/2304/05/2310/08/2309/11/2307/03/24----

Upcoming sector events for Oncternal Therapeutics, Inc.

2024-04-26 GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
2024-04-26 GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-28 BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-04-28 SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
2024-04-28 JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
2024-04-28 MORPHOSYS AG: Q1 2024 Earnings Release
2024-04-29 04:05 pm QIAGEN N.V.: Q1 2024 Earnings Release
2024-04-29 CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
2024-04-30 DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Oncternal Therapeutics, Inc.

Today 01:00 am BB BIOTECH AG: Q1 2024 Earnings Release
Today BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
Today PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
Today HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
Today BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
Today CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
2024-04-25 07:00 am MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
2024-04-25 02:00 am PURETECH HEALTH PLC: Q4 2023 Earnings Release
2024-04-24 FORMYCON AG: Q4 2023 Earnings Release
2024-04-24 PHARMARON BEIJING CO., LTD.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. ONCT Stock
  4. Calendar Oncternal Therapeutics, Inc.